BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2601582)

  • 1. Possible dopaminergic system involvement in LH and PRL responses to naltrexone treatment.
    Yogev L; Gottreich A; Homonnai ZT; Paz GF
    Life Sci; 1989; 45(24):2343-9. PubMed ID: 2601582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood luteinizing hormone and prolactin concentrations in response to naltrexone challenge: studies on rats with diabetes induced by different doses of streptozotocin.
    Yogev L; Yavetz H; Gottreich A; Oppenheim D; Homonnai ZT; Paz G
    Life Sci; 1994; 54(4):261-6. PubMed ID: 8289586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of blockade of dopaminergic receptors on acetylcholine (Ach)-induced alterations of plasma gonadotropin and prolactin (Prl) in conscious ovariectomized rats.
    Vijayan E; McCann SM
    Brain Res Bull; 1980; 5(1):23-9. PubMed ID: 6767524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opiate system involvement in the control of LH secretion in diabetic and normoglycemic male rats.
    Yogev L; Gottreich A; Brezner E; Paz GF; Homonnai ZT
    Life Sci; 1987 Aug; 41(5):585-90. PubMed ID: 3600195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for dopaminergic regulation of prolactin and a luteotropic complex in the ferret.
    Agu GO; Rajkumar K; Murphy BD
    Biol Reprod; 1986 Oct; 35(3):508-15. PubMed ID: 3539212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of naltrexone, an opioid receptor antagonist, on plasma LH levels in common carp (Cyprinus carpio L.).
    Sokolowska-Mikolajczyk M; Socha M; Mikolajczyk T; Chyb J; Epler P
    Comp Biochem Physiol C Toxicol Pharmacol; 2002 Apr; 131(4):417-24. PubMed ID: 11976056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of GnRH agonist and neural antagonists on stress-blockade of LH and prolactin surges induced by 17beta-estradiol in ovariectomized rats.
    Kam KY; Park YB; Cheon MS; Kang SS; Kim K; Ryu K
    Yonsei Med J; 2002 Aug; 43(4):482-90. PubMed ID: 12205737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteinizing hormone secretion as a response to a second naltrexone administration.
    Yogev L; Gottreich A; Homonnai ZT; Yavetz H; Paz GF
    Proc Soc Exp Biol Med; 1990 Oct; 195(1):22-5. PubMed ID: 2399258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of anaesthetics on PRL and LH secretion in rats. Importance of pre-anaesthetic adaptation and involvement of monoaminergic neurons.
    Matzen S; Knigge U; Warberg J
    Acta Endocrinol (Copenh); 1987 Aug; 115(4):528-36. PubMed ID: 3630543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possible mechanisms of the interaction between gonadotropins and prolactin in an experimental hyperprolactinemia model].
    Tresguerres JA; Esquifino AI
    Acta Physiol Lat Am; 1983; 33(3):257-74. PubMed ID: 6424409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the antidopaminergic drug veralipride on LH and PRL secretion in postmenopausal women.
    Fioretti P; Cagnacci A; Paoletti AM; Gambacciani M; Soldani R; Mauro GA; Spinetti A; Melis GB
    J Endocrinol Invest; 1989 May; 12(5):295-301. PubMed ID: 2549113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seasonal short-term effects of naltrexone on LH secretion in male carp (Cyprinus carpio L.).
    Sokolowska-Mikolajczyk M; Socha M; Mikolajczyk T; Chyb J; Epler P
    Comp Biochem Physiol C Toxicol Pharmacol; 2002 Mar; 131(3):379-85. PubMed ID: 11912062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of blockade of dopamine receptors on the inhibition of episodic luteinizing hormone release during electrical stimulation of the arcuate nucleus in ovariectomized rats.
    Gallo RV
    Endocrinology; 1978 Apr; 102(4):1026-35. PubMed ID: 744005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of suckling-induced prolactin release by mu- and kappa-opioid antagonists.
    Baumann MH; Rabii J
    Brain Res; 1991 Dec; 567(2):224-30. PubMed ID: 1667901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for central nervous system (CNS) involvement in inhibition of luteinizing hormone (LH) release by dopamine receptor stimulation.
    Owens RE; Fleeger JL; Harms PG
    Endocr Res Commun; 1980; 7(2):99-105. PubMed ID: 6997016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between luteinizing hormone and prolactin pulses in ovariectomized rats with or without dopamine inhibition.
    Pohl CR; Weiner RI; Smith MS
    Endocrinology; 1988 Sep; 123(3):1591-7. PubMed ID: 3402398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of brain dopamine in prolactin secretion induced by a synthetic Met5-enkephalin analogue in rats.
    Matsushita N; Kato Y; Katakami H; Shimatsu A; Imura H
    Endocrinol Jpn; 1982 Jun; 29(3):277-85. PubMed ID: 7173110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin suppression by (-) delta-9-tetrahydrocannabinol (THC): involvement of serotonergic and dopaminergic pathways.
    Kramer J; Ben-David M
    Endocrinology; 1978 Aug; 103(2):452-7. PubMed ID: 744093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of dopamine in prolactin release induced by electrical stimulation of the hypothalamus of the female turkey (Meleagris gallopavo).
    el Halawani ME; Youngren OM; Silsby JL; Phillips RE
    Gen Comp Endocrinol; 1991 Dec; 84(3):360-4. PubMed ID: 1808016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No acute effect of pimozide on the plasma GH levels in acromegaly.
    Nortier JW; Croughs RJ; Donker GH; Thijssen JH; Schwarz F
    Acta Endocrinol (Copenh); 1983 Aug; 103(4):461-8. PubMed ID: 6613492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.